Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 5c; Trims FY12 EPS Range
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $87.36 --0%
Revenue Growth %: +11.1%
Financial Fact:
Basic (in shares): 213.2M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.1%
Financial Fact:
Basic (in shares): 213.2M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q1 EPS of $0.53, $0.05 better than the analyst estimate of $0.48. Revenue for the quarter came in at $459.2 million versus the consensus estimate of $449.75 million.
Edwards Lifesciences Corp. sees FY2012 EPS of $2.58-$2.68, versus prior guidance of $2.70-$2.80 and the consensus of $2.67.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Edwards Lifesciences Corp. sees FY2012 EPS of $2.58-$2.68, versus prior guidance of $2.70-$2.80 and the consensus of $2.67.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Morgan Stanley Downgrades Melco Resorts (MLCO) to Equalweight
- Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
